- Home
- FBIO vs XTNT Comparison
FBIO vs XTNT Comparison
Compare FBIO & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- XTNT
- Stock Information
- Founded
- FBIO 2006
- XTNT N/A
- Country
- FBIO United States
- XTNT United States
- Employees
- FBIO N/A
- XTNT N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBIO Health Care
- XTNT Health Care
- Exchange
- FBIO Nasdaq
- XTNT Nasdaq
- Market Cap
- FBIO 88.7M
- XTNT 82.1M
- IPO Year
- FBIO N/A
- XTNT N/A
- Fundamental
- Price
- FBIO $3.38
- XTNT $0.61
- Analyst Decision
- FBIO Strong Buy
- XTNT
- Analyst Count
- FBIO 2
- XTNT 0
- Target Price
- FBIO $16.50
- XTNT N/A
- AVG Volume (30 Days)
- FBIO 1.1M
- XTNT 89.5K
- Earning Date
- FBIO 08-14-2025
- XTNT 08-12-2025
- Dividend Yield
- FBIO N/A
- XTNT N/A
- EPS Growth
- FBIO N/A
- XTNT N/A
- EPS
- FBIO N/A
- XTNT N/A
- Revenue
- FBIO $59,301,000.00
- XTNT $127,766,000.00
- Revenue This Year
- FBIO $51.59
- XTNT $13.03
- Revenue Next Year
- FBIO $44.74
- XTNT N/A
- P/E Ratio
- FBIO N/A
- XTNT N/A
- Revenue Growth
- FBIO N/A
- XTNT 15.16
- 52 Week Low
- FBIO $1.33
- XTNT $0.33
- 52 Week High
- FBIO $3.90
- XTNT $0.78
- Technical
- Relative Strength Index (RSI)
- FBIO 71.65
- XTNT 46.91
- Support Level
- FBIO $2.79
- XTNT $0.59
- Resistance Level
- FBIO $3.90
- XTNT $0.65
- Average True Range (ATR)
- FBIO 0.25
- XTNT 0.04
- MACD
- FBIO 0.12
- XTNT -0.00
- Stochastic Oscillator
- FBIO 73.04
- XTNT 40.00
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.